Table 2.

NF-κB activation in 60 breast cancer cases with different status of ER and HER2 expression

Group	n	Positive rate (%)
ER^-/HER2⁺^*	18	77.8(14/18)
ER^-/HER2^-	18	33.3 (6/18)
ER⁺/HER2⁺	12	41.7 (5/12)
ER⁺/HER2^-	12	41.7 (5/12)

↵* vs. ER^-/HER2^-, ER⁺/HER⁺ and ER⁺/HER2^- groups (P<0.01 ).